Evaluation of the Performance of QuantiFERON-TB Gold Plus Assay in Human Immunodeficiency Virus Infection

Evaluation of the Performance of QuantiFERON-TB Gold Plus Assay in Human Immunodeficiency Virus Infection

Introduction: Individuals co-infected with human immunodeficiency virus (HIV) and Mycobacterium tuberculosis have an increased risk of the reactivation of latent tuberculosis (TB) infection (LTBI) to active TB. The addition of peptides to stimulate CD8+ T cells is expected to increase the sensitivit...

Full description

Bibliographic Details
Main Authors:	Melike YAŞAR DUMAN, Cengiz ÇAVUŞOĞLU, İmre ALTUĞLU, Ayşin ZEYTİNOĞLU, Ayşe Deniz GÖKENGİN, Tansu Gülbahar AYDOĞAN, Mehmet Nurullah ORMAN
Format:	Article
Language:	Turkish
Published:	Galenos Yayinevi 2022-08-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	quantiferon-tb gold plus active tuberculosis human immunodeficiency virus latent tuberculosis infection mycobacterium tuberculosis
Online Access:	https://mjima.org/abstract.php?id=325

Similar Items

Evaluating the diagnostic accuracy of QIAreach QuantiFERON-TB compared to QuantiFERON-TB Gold Plus for tuberculosis: a systematic review and meta-analysis
by: Shima Mahmoudi, et al.
Published: (2024-06-01)

Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients
by: Cengiz Çavuşoğlu, et al.
Published: (2021-05-01)

Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection
by: Elisa Petruccioli, et al.
Published: (2016-01-01)

Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit
by: Elisa Petruccioli, et al.
Published: (2016-01-01)

Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test
by: Aabye Martine G, et al.
Published: (2012-12-01)

QuantiFERON® TB GOLD’ s applications in the tuberculosis disease
by: Maria Saladino, et al.
Published: (2014-06-01)

Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus
by: Elia Noemi Gallegos Morales, et al.
Published: (2017-05-01)

Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
by: Salvatore Nisticò, et al.
Published: (2010-03-01)

QuantiFERON-TB reversion in children and adolescents with tuberculosis
by: Paula Rodríguez-Molino, et al.
Published: (2024-03-01)

Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China
by: Peng Lu, et al.
Published: (2025-02-01)

QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01)

Diagnostic utility of QuantiFERON-TB gold (QFT-G) in active pulmonary tuberculosis
by: Ahmed Anwar, et al.
Published: (2015-01-01)

Comparative Evaluation of Standard E TB-Feron ELISA and QuantiFERON-TB Gold Plus Assays in Patients with Tuberculosis and Healthcare Workers
by: In Young Yoo, et al.
Published: (2021-09-01)

Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients
by: Sheng-Wei Pan, et al.
Published: (2023-10-01)

QuantiFERON-TB Gold In-Tube test in active tuberculosis patients and healthy adults
by: Benjawan Phetsuksiri, et al.
Published: (2018-10-01)

QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1–14 in a Country with a Low Tuberculosis Incidence
by: DAGMARA BORKOWSKA-TATAR, et al.
Published: (2021-05-01)

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease
by: K. Fukushima, et al.
Published: (2022-01-01)

The Role of QuantiFERON-TB Gold Plus in Mycobacterium Tuberculosis Detection in a Severe HIV Immunocompromised Patient—Case Report
by: Florentina Dumitrescu, et al.
Published: (2021-11-01)

Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
by: Khaled H. Mohamed, et al.
Published: (2012-07-01)

Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
by: Kamran Kadkhoda, et al.
Published: (2023-02-01)

Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis
by: Yu Zhang, et al.
Published: (2023-01-01)

Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients
by: Ekrem Cengiz Seyhan, et al.
Published: (2016-01-01)

Evaluation of QuantiFERON-TB Gold for the Diagnosis of <i>Mycobacterium tuberculosis</i> Infection in HTLV-1-Infected Patients
by: Luana Leandro Gois, et al.
Published: (2024-11-01)

QuantiFERON-TB Gold and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Children
by: Hossein Masoumi Asl, et al.
Published: (2015-09-01)

Evaluation of concordance of new QuantiFERON-TB Gold Plus platforms for Mycobacterium tuberculosis infection diagnosis in a prospective cohort of household contacts
by: Cinthya Ruiz-Tagle, et al.
Published: (2024-08-01)

QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG
by: Séverine Carrère-Kremer, et al.
Published: (2022-04-01)

Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patients
by: Evangeline Ann Daniel, et al.
Published: (2025-12-01)

Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study
by: Yuzhen Xu, et al.
Published: (2022-04-01)

Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation
by: Babu Kalpana, et al.
Published: (2009-01-01)

Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
by: Chun-Yu Cheng, et al.
Published: (2015-09-01)

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
by: Sara Debulpaep, et al.
Published: (2019-07-01)

Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional study
by: Davaasambuu Ganmaa, et al.
Published: (2019-06-01)

Comparative Evaluation of Diagnostic Performance: Standard E TB Feron ELISA vs QuantiFERON-TB Gold Plus for Latent Tuberculosis Infection Detection in Diverse Risk Groups in Bangladesh
by: Uddin MKM, et al.
Published: (2024-09-01)

QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia
by: Selam Niguse, et al.
Published: (2018-05-01)

Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran
by: Ehsan Mostafavi, et al.
Published: (2016-07-01)

From Latent Tuberculosis Infection to Tuberculosis. News in Diagnosticsb (QuantiFERON-Plus)
by: Dagmara I. Borkowska, et al.
Published: (2017-03-01)

The seroconversion rate of QuantiFERON-TB gold in-tube test in psoriatic patients receiving anti-interleukin-23 monoclonal antibodies
by: Yi-Wei Huang, et al.
Published: (2022-01-01)

Assessing the effects of diabetes mellitus on the monocyte-to-lymphocyte ratio and the QuantiFERON-TB gold plus assays for tuberculosis treatment monitoring: a prospective cohort study
by: Paulo Ranaivomanana, et al.
Published: (2025-01-01)

Diagnostic utility of QuantiFERON-TB Gold and Xpert MTB/RIF combined with adenosine deaminase in tuberculous pleural effusion: a prospective study
by: Hassan Aref
Published: (2017-11-01)

Latent tuberculosis infection: the possibility of quantiferon test
by: T.V. Tlustova, et al.
Published: (2018-09-01)